Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
This round of financing will be exclusively funded by Shanghai Healthcare Capital (“SHC”), managed by SIIC Capital, where Shanghai Pharma is one of the founding strategic cornerstone LPs.
The company has two products under development. The first is BP-ADJUST™, a new device in the form of a wristwatch that monitors blood pressure and heart rate and uses the information to deliver unique energy therapy to control BP. The second product is BP-ADJUST™ CV.
Founded in 2011, RapidAI makes the most-widely used advanced cerebrovascular imaging products for patient care, research, and clinical trials. This funding will support the continued advancement of the Rapid® platform and world-class clinical products.